Browsing: Podcasts

The Oncology Journal Club Podcast Episode 38 In today’s special ASCO 2021 episode Craig Underhill talks to Lisa Horvath and Craig Gedye about all things GU cancer. It’s a thorough and entertaining discussion covering practice changing developments and controversial trials. We hope you enjoy listening… drop us a line on Twitter with any comments. This Week’s Papers: Fizazi, K., et al. A phase 3 trial with a 2×2 factorial design of abiraterone acetate plus prednisone and/or local radiotherapy in men with de novo metastatic castration-sensitive prostate cancer (mCSPC): First results of PEACE-1. J Clin Oncol 39, 2021 (suppl 15; abstr…

The Oncology Journal Club Podcast Episode 37: Listen here In today’s special ASCO 2021 episode Craig Underhill talks to Gilberto Lopes and Mel Moore about all things lung cancer. It’s a thorough and entertaining discussion covering practice changing developments and controversial trials. We hope you enjoy listening… drop us a line on Twitter with any comments. This Week’s Papers: Reck, M. et al. First-line nivolumab (NIVO) plus ipilimumab (IPI) plus two cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients with advanced non-small cell lung cancer (NSCLC): Two-year update from CheckMate 9LA. J Clin Oncol 39, 2021 (suppl 15; abstr…

The Oncology Journal Club Episode 36 In today’s special episode of The Oncology Journal Club podcast, Eva Segelov and Craig Underhill talk to Professor Raina MacIntyre about COVID-19: One Year On. If you’re not familiar with Raina, she heads the Biosecurity Program at the Kirby Institute – you can read her full bio below. The episode is packed full of information and frank analysis covering a wide range of topics including lack of PPE and moral injury, the different COVID variants and why vaccination is our only exit strategy. It’s very refreshing to hear one of the world’s leading pandemic experts…

The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 35 in our series The Oncology Journal Club. Do you think sugary drinks could be responsible for the increased rates of colorectal cancer that we are seeing in young adults? Join us this week as Hans Prenen finds out. Craig Underhill talks us through the TITAN Study and the problem of not acknowledging investigators. And Eva Segelov talks to Kristi Milley about getting meaningful engagement from consumers. You’ll also hear the amazing article of the week on Chernobyl and climate change, the final installment of…

Recapture Life trial podcast with Rachael Babin and Ursula Sansom-Daly In today’s episode of The Oncology Podcast our host Rachael Babin discusses the Recapture Life Trial with Ursula Sansom-Daly, as a follow up to our popular ‘Making Telehealth Human’ podcast. The ‘Recapture Life’ trial is a recently published large randomised control trial examining the efficacy of a new online psychological support program for adolescent and young adult cancer survivors. The data revealed some very interesting implications for ‘who’ online support may work best for, and ‘when’ this support is best delivered. Ursula Sansom-Daly is a Clinical Psychologist for the Sydney…

In today’s special episode of The Oncology Podcast, our Host Rachael Babin chats to Professor Damien Bolton and Chris McNamara about why not all prostate cancers are the same. The discussion is focused on the way men with advanced prostate cancer feel and the emotions they experience as well as important information gaps that may impact on their ability to make shared decisions about their clinical management. Rachael, Damien and Chris explore the perceptions of patients living with different stages of prostate cancer across the Asia-Pacific (APAC) region including Australia, Japan and China and review the PCFA’s Prostate Cancer Survivorship…

The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 34 in our series The Oncology Journal Club. This week we have another great episode for you in our usual format. Craig Underhill gets us started by talking us through primary tumour resection plus chemotherapy versus chemotherapy alone for metastatic colorectal cancer patients. Hans Prenen gets stuck into the use of tipifarnib in head and neck squamous cell carcinoma with HRAS mutations and Eva Segelov continues to guide us through what she calls a ‘manifesto for good study design’ – a key paper from our…

Was Beethoven’s death-the result of medical malpractice? This week the OJC team tackle this crucial question plus the microbiome, trial design bias, five year outcomes for metastatic non-small-cell lung cancer and much more. The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 33 in our series The Oncology Journal Club. Was Beethoven’s death the result of medical malpractice? This week the OJC team tackle this crucial question plus the microbiome, trial design bias, five year outcomes for metastatic non-small-cell lung cancer and much more… Hans Prenen gets us started by talking us through the…

The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 31 in our series The Oncology Journal Club. This week we have a very special episode – we are exploring what happens when the oncologist gets cancer. Three fantastic guests share their unique, very personal, stories of cancer with us. We start with a giant in the Australian oncology world – Professor Grant McArthur who is director of the VCCC. We hear from our friend Mark Lewis from the US who shares his experiences as a physician-patient who has multiple neuroendocrine neoplasia type 1.…

Frail Patients, Fans, Fingerprints and much more! The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 31 in our series The Oncology Journal Club. This week’s episode is in our usual format and has so much detail squeezed into 34 minutes, with discussion of prominent papers, practice changing trials, Quick Bites and much more. Hans Prenen gets stuck into bispecific antibodies, Craig Underhill takes us through ASCO’s Report on Progress Against Cancer and Eva discusses Checkmate 577, a practice changing clinical trial exploring the role of adjuvant nivolumab in esophageal cancer. About The Oncology…

1 2 3 4 7